9 Ways Perimenopause Complicates Multiple Sclerosis and Why Neurologists Often Miss the Connection
The women who reach out about this topic are often frustrated in a very specific way — they've been managing their MS carefully for years, and then perimenopause arrives and everything feels like it's falling apart again. The hardest part is that their neurologist sees a stable MRI and says nothing has changed, while they're living in a body that clearly has. That gap between the scan and the lived experience is real, and it deserves a proper explanation.
Learn more about Rose →Estrogen Loss Removes a Natural Anti-Inflammatory Shield
Estrogen — particularly estradiol — actively suppresses pro-inflammatory cytokines, including TNF-alpha and interleukin-17, both of which play a direct role in MS lesion activity. When estradiol drops during perimenopause, this brake on neuroinflammation loosens, potentially allowing existing MS-related inflammation to become more active even without new demyelinating lesions forming. This is why a woman can have a stable MRI and still experience a genuine worsening of symptoms — the inflammatory environment in the CNS has shifted without leaving a visible mark on imaging.
Cognitive Symptoms From Both Conditions Are Nearly Identical
MS-related cognitive dysfunction and perimenopausal brain fog both present as word-finding difficulty, slowed processing speed, and working memory gaps — making it almost impossible to tell them apart without careful longitudinal tracking. Neurologists assessing MS-related cognition are not always screening for hormonal status, so they may interpret a new cognitive dip as disease progression and escalate treatment accordingly. For women in their mid-40s with MS, a detailed menstrual history and hormone-level check alongside cognitive testing would give a far more complete picture.
Heat Sensitivity Gets Significantly Worse as Estrogen Drops
The Uhthoff phenomenon — where MS symptoms temporarily worsen with rises in body temperature — is well documented, and estrogen normally helps regulate core thermoregulation through hypothalamic pathways. In perimenopause, the dysregulation of the hypothalamus that causes hot flashes also disrupts the body's ability to manage heat load efficiently, making Uhthoff episodes more frequent and more severe. Women who previously managed heat sensitivity with basic precautions may find those strategies suddenly insufficient, not because their MS has progressed, but because their thermoregulatory baseline has shifted.
Fatigue Compounds in a Way That Defies Standard MS Fatigue Management
MS fatigue is already one of the most debilitating and least understood symptoms of the disease; perimenopausal fatigue — driven by disrupted sleep, HPA axis dysregulation, and declining estrogen's effect on mitochondrial function — layers on top of it in ways that standard fatigue-management strategies don't address. Neurologists assessing fatigue in MS typically look at relapse activity or depression screening, but rarely ask about sleep quality, night sweats, or menstrual cycle changes that would point toward a hormonal contribution. The combined fatigue load during this window can be severe enough to significantly impair function in women who were previously coping well.
Sleep Disruption From Night Sweats Accelerates Neurological Symptoms
Sleep is when the glymphatic system — the brain's waste-clearance mechanism — does its most critical work, flushing metabolic byproducts including those associated with neuroinflammation. Perimenopausal night sweats fragmenting sleep therefore don't just cause tiredness; they impair this clearance process and can worsen the neurological symptom burden in someone whose CNS is already under MS-related stress. Research in MS populations consistently shows that poor sleep correlates with worse fatigue, worse cognition, and lower quality of life — and fixing the sleep is often more impactful than it first appears.
Mood Symptoms Are Attributed to MS or Depression When Hormones Are the Driver
Anxiety, low mood, and emotional lability are common in both MS and perimenopause, and the standard clinical response in an MS patient is to screen for MS-related depression — a real and serious condition — and potentially add antidepressant treatment. What frequently goes unexamined is whether the mood shift tracked with menstrual cycle changes, worsened in the luteal phase, or arrived alongside other perimenopausal symptoms like disrupted sleep or cycle irregularity. Treating a hormonally-driven mood change with an antidepressant rather than addressing the underlying hormonal instability is unlikely to resolve the problem and may add side effects to an already complex medication burden.
Bladder Symptoms From Both Conditions Overlap Almost Completely
Neurogenic bladder — urgency, frequency, incomplete emptying, and incontinence — is one of the most common and distressing MS symptoms, affecting up to 80% of people with the disease; genitourinary syndrome of menopause (GSM) produces urgency, frequency, and incontinence through an entirely different mechanism involving estrogen receptor depletion in the bladder and urethra. When a woman with MS reports worsening bladder symptoms in her late 40s, the automatic assumption is MS progression, but if local estrogen receptors have become depleted, the bladder urgency may be largely or partly GSM — a condition that responds well to topical estrogen, which is not going to show up on a neurological assessment.
Estrogen's Role in Myelin Maintenance Means Its Loss Can Slow Repair
Estradiol has been shown in preclinical and some clinical research to promote remyelination by supporting oligodendrocyte precursor cell activity — the cells responsible for repairing myelin damage after MS lesions. During perimenopause, as estradiol levels become erratically low, this remyelination support diminishes, meaning existing damage may repair more slowly or less completely than it did when the woman was in her 30s. This is not disease progression in the traditional sense, but it can result in a gradual accumulation of residual symptoms from lesions that previously resolved more cleanly.
Neurologists Rarely Have Menopause Training, and Gynecologists Rarely Understand MS
The structural gap in specialist training means that the physician managing a woman's MS is typically not asking about perimenopausal symptoms, and the physician she might see about perimenopausal symptoms is not fully equipped to consider how hormonal changes interact with her neurological disease. Studies on physician knowledge of menopause consistently show that even internists and gynecologists have significant gaps; neurologists, whose training focuses elsewhere, are rarely an exception. Women with MS navigating perimenopause are disproportionately likely to fall through this gap unless they advocate specifically for a joined-up conversation — ideally with a menopause-informed clinician who is also briefed on their MS history.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.